Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02770170
Recruitment Status : Active, not recruiting
First Posted : May 12, 2016
Last Update Posted : October 2, 2019
Sponsor:
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 25, 2019
Estimated Study Completion Date : August 25, 2020